company background image
MPH logo

Master Pharm WSE:MPH Stock Report

Last Price

zł6.05

Market Cap

zł119.7m

7D

0%

1Y

50.1%

Updated

23 Sep, 2022

Data

Company Financials

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

MPH Stock Overview

Master Pharm SA designs and manufactures diet supplements, special nutritional food, dietary products, cosmetics, medical devices, and other consumables in Poland.

MPH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Master Pharm SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Master Pharm
Historical stock prices
Current Share Pricezł6.05
52 Week Highzł6.05
52 Week Lowzł3.85
Beta0.58
1 Month Change0%
3 Month Change0.83%
1 Year Change50.12%
3 Year Change8.42%
5 Year Change21.98%
Change since IPO-12.32%

Recent News & Updates

Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Feb 05
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes

Dec 13
Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes

Recent updates

Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Feb 05
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes

Dec 13
Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes

A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)

May 25
A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends

Mar 30
Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends

Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?

Mar 02
Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?

I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease

Feb 04
I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease

Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?

Jan 08
Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?

Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital

Dec 18
Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital

Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Nov 27
Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Shareholder Returns

MPHPL Personal ProductsPL Market
7D0%-2.0%-0.7%
1Y50.1%56.8%24.7%

Return vs Industry: MPH exceeded the Polish Personal Products industry which returned -24.9% over the past year.

Return vs Market: MPH exceeded the Polish Market which returned -30.5% over the past year.

Price Volatility

Is MPH's price volatile compared to industry and market?
MPH volatility
MPH Average Weekly Movementn/a
Personal Products Industry Average Movement5.9%
Market Average Movement5.0%
10% most volatile stocks in PL Market9.7%
10% least volatile stocks in PL Market3.1%

Stable Share Price: MPH has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine MPH's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2002n/aJacek Franasikwww.masterpharm.pl

Master Pharm SA designs and manufactures diet supplements, special nutritional food, dietary products, cosmetics, medical devices, and other consumables in Poland. It also offers contract manufacturing services and product document preparation services. In addition, the company imports and exports supplements and medical devices; and engages in designing, manufacturing, subcontracting, and distributing, as well as conformity assessment for CE mark, and registration of medical devices.

Master Pharm SA Fundamentals Summary

How do Master Pharm's earnings and revenue compare to its market cap?
MPH fundamental statistics
Market capzł119.72m
Earnings (TTM)zł1.68m
Revenue (TTM)zł79.17m

71.2x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MPH income statement (TTM)
Revenuezł79.17m
Cost of Revenuezł38.67m
Gross Profitzł40.50m
Other Expenseszł38.82m
Earningszł1.68m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Nov 17, 2022

Earnings per share (EPS)0.085
Gross Margin51.15%
Net Profit Margin2.12%
Debt/Equity Ratio16.1%

How did MPH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.